Insulin Cost Guide: $35 Cap, Biosimilars, and How to Pay Less
Insulin costs between $2 and $10 to manufacture, yet Americans routinely pay $300 or more per vial. About 8.4 million Americans depend on insulin daily, and 1 in 4 report rationing it because of cost. This guide covers every realistic way to lower your insulin bill in 2026, from the federal $35 cap to biosimilars, manufacturer programs, state laws, and lesser-known alternatives.
The Insulin Pricing Scandal
Insulin was discovered in 1921, and its patent was sold to the University of Toronto for $1 so it could be available to everyone. More than a century later, three companies control roughly 90% of the global insulin market: Eli Lilly, Novo Nordisk, and Sanofi. What happened in between is one of the most egregious examples of pharmaceutical price manipulation in history.
The Shadow Pricing Problem
Between 2002 and 2023, the list price of Humalog rose from $21 per vial to over $330. Lantus went from $35 to $340+. NovoLog followed a nearly identical trajectory. This was not a coincidence.
Investigations by Congress and the American Diabetes Association found a pattern of “shadow pricing,” where each manufacturer raised prices in lockstep with the others. When Lilly increased the price of Humalog, Novo Nordisk raised NovoLog by a comparable amount within weeks, and vice versa. No formal collusion was ever proven, but the outcome was the same: prices rose by over 1,000% while manufacturing costs stayed flat.
The insulin supply chain also inflates costs. Pharmacy Benefit Managers (PBMs) negotiate rebates from manufacturers, but those rebates rarely reach patients. The higher the list price, the larger the rebate, and the more PBMs earn. This creates a perverse incentive where everyone in the supply chain benefits from higher list prices except the person injecting the insulin.
Insulin List Price vs. Manufacturing Cost
The good news: pressure from legislation, biosimilar competition, and public outcry has finally started to push real costs down. Every section below represents a concrete path to paying less.
The IRA $35 Monthly Cap
The Inflation Reduction Act (IRA), signed in August 2022, introduced a $35 per month cap on out-of-pocket insulin costs. This is the single most significant insulin affordability provision in U.S. law. Here is exactly how it works.
Who Qualifies
- +Medicare Part D enrollees (all Part D and Medicare Advantage drug plans must honor the cap starting January 2023)
- +Some marketplace/ACA plans that have voluntarily adopted the cap (check your specific plan)
- +Some employer plans that voluntarily match the cap (many large employers followed suit after the IRA passed)
What the Cap Covers
- All insulin products on the plan formulary (vials, pens, cartridges)
- No deductible required for insulin (Medicare Part D eliminated the insulin deductible)
- $35 per month per insulin prescription (90-day supply caps at $105)
- Applies to both brand-name and biosimilar insulins on formulary
The Gap: Who Is NOT Covered
- !Uninsured individuals are not covered by any cap (but see manufacturer programs below)
- !Commercial/employer insurance has no federal mandate (Congress removed the provision before passage). However, many states have their own caps.
- !Insulin billed through the medical benefit (common for insulin pump users) may not be subject to the pharmacy-benefit cap
- !Non-formulary insulins require a formulary exception or prior authorization to qualify
How to confirm your plan participates
Call the member services number on the back of your insurance card and ask: “Does my plan cap insulin copays at $35 per month?” For Medicare Part D, the answer is always yes. For employer plans, your HR benefits team can confirm. You can also check your plan’s Summary of Benefits and Coverage (SBC) document, which lists cost-sharing details for covered drugs.
State Insulin Price Caps
Because the federal $35 cap only applies to Medicare Part D, many states have passed their own insulin price cap laws that cover state-regulated commercial insurance plans. These caps do not apply to self-funded employer plans (governed by ERISA), but they protect millions of people on individual, small-group, and state employee plans.
State Insulin Copay Caps (Selected States)
| State | Monthly Cap | Notes |
|---|---|---|
| Colorado | $100/month | First state to pass a cap (2019). Applies to state-regulated plans. |
| California | $35/30-day supply | Covers state-regulated commercial, Medi-Cal already low-cost. |
| Illinois | $35/month | Covers all state-regulated insurance plans. |
| Maine | $35/30-day supply | Also includes an emergency 30-day access provision. |
| New York | $30/30-day supply | One of the lowest caps in the country. |
| Washington | $35/30-day supply | Also includes an emergency access program. |
| Connecticut | $25/month | Among the lowest state caps. |
| New Mexico | $25/month | Covers state-regulated group and individual plans. |
| West Virginia | $35/month | Includes both insulin and insulin devices. |
| Virginia | $50/month | Applies to state-regulated individual and group plans. |
Important limitation
State caps only apply to “fully insured” plans regulated by the state. If your employer self-funds its health plan (common among large companies), state law does not apply because ERISA preempts it. Ask your HR department whether your plan is fully insured or self-funded.
If your state has no cap or you are on a self-funded plan, the manufacturer programs, biosimilar options, and other strategies below are your best alternatives.
Still paying too much for insulin?
Our Bill Defense experts can identify savings programs you qualify for, appeal insurance denials, and negotiate lower costs on your behalf. You only pay if we save you money.
Biosimilar Insulin: The Real Game Changer
Biosimilars are the insulin equivalent of generic drugs. They are FDA-approved copies of brand-name biologic insulins, tested to be clinically identical in safety, purity, and effectiveness. Unlike the caps and programs above (which still involve paying the same manufacturers), biosimilars introduce actual competition into the insulin market.
Key Biosimilar Insulins Available in 2026
Biosimilar to Lantus. First interchangeable biosimilar insulin approved in the U.S. About 65% cheaper than brand-name Lantus. Available in both vials (~$100) and pens (~$150 for a box of 5). Because it is designated “interchangeable,” your pharmacist can substitute it for Lantus without calling your doctor.
Another biosimilar to Lantus, manufactured by Lilly. Priced significantly below brand Lantus. Available in KwikPen format. Typically 50-60% cheaper than Lantus at retail.
Lilly’s own authorized generic of Humalog. Identical product, different label, dramatically lower price. Available for $25 to $50 per vial without insurance at many pharmacies. This is one of the most affordable rapid-acting insulin options available.
How to ask your doctor for a biosimilar switch
Say: “I’m concerned about the cost of my insulin. Can you prescribe a biosimilar or authorized generic instead?” Be specific:
- • If you take Lantus, ask about Semglee or Rezvoglar
- • If you take Humalog, ask about insulin lispro (authorized generic)
- • If you take NovoLog, ask about insulin aspart options
For interchangeable biosimilars like Semglee, your pharmacist can often make the switch without a new prescription.
Manufacturer Savings Programs
All three major insulin manufacturers now offer significant savings programs. Some of these programs work regardless of whether you have insurance, making them critical lifelines for the uninsured.
Eli Lilly: Insulin Value Program
Cost: $35 per month per insulin prescription
Who qualifies: Anyone with or without insurance. No income requirements. Covers all Lilly insulins (Humalog, Humulin, Lyumjev, insulin lispro, Rezvoglar).
How to enroll: Visit InsulinAffordability.com, register, and receive a savings card. Present it at any participating pharmacy.
Key detail: This is one of the most straightforward programs. There is no income verification, no lengthy application, and it works at virtually every pharmacy. If you use any Lilly insulin, there is almost no reason not to use this.
Novo Nordisk: PAP and Cash-Pay Options
Patient Assistance Program (PAP): Free insulin for qualifying patients. Income must be at or below 400% of the Federal Poverty Level (roughly $62,400 for a single person in 2026). No insurance, or underinsured.
My$99Insulin Program: Up to 3 vials or 2 packs of pens of any Novo Nordisk insulin for $99 per month. Available to uninsured and commercially insured patients. No income requirement.
How to enroll: Visit NovoCare.com or call 1-888-668-6444. The PAP requires an application and proof of income. The $99 program requires a savings card from the website.
Sanofi: Insulins ValYou Savings Program
Cost: $35 per month for one or two Sanofi insulins (Lantus, Toujeo, Admelog, Apidra) for uninsured patients. Commercially insured patients can get copay assistance.
Who qualifies: U.S. residents with or without insurance. Different tiers for uninsured vs. insured patients.
How to enroll: Visit Sanofi.com/patient-assistance or call 1-888-847-4877. Download the savings card to use at any participating pharmacy.
Pro tip: Stack your savings
You cannot typically combine a manufacturer savings card with Medicare or Medicaid. However, if you have commercial insurance, you can often use a manufacturer copay card to bring your copay down to $0 to $35, and the manufacturer pays the difference. Check each program’s terms for specifics.
Walmart ReliOn Insulin: $25 Per Vial OTC
Walmart’s ReliOn brand insulin is available over the counter (no prescription needed) for approximately $25 per vial at Walmart and Sam’s Club pharmacies. For someone in a financial crisis who needs insulin today, this may be the fastest and most accessible option.
Available ReliOn Products
Important Caveat: This Is Older Insulin
ReliOn insulin is human insulin (Regular and NPH), not modern analog insulin (like Humalog, NovoLog, or Lantus). There are real clinical differences:
- !Slower onset: Regular insulin takes 30 to 60 minutes to start working, versus 15 minutes for rapid-acting analogs. You must plan meals carefully and inject 30 minutes before eating.
- !Different dosing schedules: NPH insulin has a pronounced peak and shorter duration than Lantus or Tresiba, which may require more frequent injections and carry higher risk of hypoglycemia.
- !Do not switch without medical guidance: If you are currently on analog insulin, do not switch to ReliOn on your own. The dosing is different, and incorrect dosing can cause dangerously low or high blood sugar. Work with your doctor or a diabetes educator.
ReliOn insulin is a legitimate, FDA-approved, life-saving option, especially for people who cannot access or afford anything else. But it is not a perfect substitute for modern analogs. If you can access biosimilars or manufacturer programs at $25 to $35 per month, those are generally better clinical options.
Overwhelmed by insulin costs and options?
CareRoute Bill Defense can help you navigate manufacturer programs, appeal insurance denials for insulin coverage, and find the lowest price available to you. No savings, no fee.
Cost Plus Drugs and International Pharmacy Options
Mark Cuban Cost Plus Drugs
Cost Plus Drugs operates on a transparent pricing model: manufacturer cost + 15% margin + $5 pharmacy fee + $5 shipping. No hidden middlemen, no PBM rebate games. They carry several insulin products at prices well below traditional pharmacy retail.
Example pricing: Insulin glargine (generic Lantus) vials for approximately $40 to $55, and insulin lispro vials for approximately $30 to $45. Prices change, so check CostPlusDrugs.com for current availability.
Cost Plus Drugs ships directly to your door. You need a valid prescription from your doctor. They do not accept insurance (the whole point is that the cash price is already lower than most insured prices for these products).
International Pharmacy Options
Insulin that costs $300+ in the U.S. often costs $30 to $60 in Canada, $20 to $40 in Mexico, and even less in other countries. The same brand-name products from the same manufacturers are sold globally at a fraction of the U.S. price.
- Canada: Humalog ~$32/vial, Lantus ~$40/vial through licensed Canadian pharmacies. Verify through CIPA (Canadian International Pharmacy Association).
- Mexico: Many border cities have pharmacies selling insulin at $20 to $40 per vial without a prescription. Millions of Americans living near the border already do this.
- State importation programs: Colorado, Florida, and several other states have established (or are establishing) formal programs to import cheaper drugs from Canada.
Note: The FDA generally prohibits importing prescription drugs, but enforcement for personal-use quantities (90-day supply or less) is minimal. Always buy from verified, licensed pharmacies.
Related Guides
12 strategies for reducing what you pay at the pharmacy, from discount cards to 340B hospitals.
How to get free or reduced-cost medications through manufacturer and nonprofit programs.
How insurers prevent copay assistance from counting toward your deductible, and how to fight back.
Frequently Asked Questions
How much does insulin cost without insurance in 2026?▼
Without insurance, a single vial of brand-name insulin (Humalog, NovoLog, Lantus) costs $275 to $400 or more at list price. However, you should never pay list price. Biosimilar insulin lispro (generic Humalog) costs $25 to $50 per vial at many pharmacies. Walmart ReliOn insulin is $25 per vial over the counter. The Lilly Insulin Value Program caps any Lilly insulin at $35 per month. Cost Plus Drugs sells insulin glargine vials for roughly $40 to $55.
Who qualifies for the $35 insulin cap under the Inflation Reduction Act?▼
The federal $35 cap applies to people enrolled in Medicare Part D and Medicare Advantage prescription drug plans. It covers all formulary insulin products (vials, pens, cartridges) with no deductible. The cap does not automatically apply to commercial insurance or the uninsured, though many states have their own caps and many insurers have voluntarily adopted the $35 limit. Ask your plan directly.
What is biosimilar insulin and is it safe?▼
Biosimilar insulin is an FDA-approved near-identical copy of a brand-name insulin product. The FDA requires biosimilars to demonstrate no clinically meaningful differences from the reference product in safety, purity, and potency. Products like Semglee (biosimilar to Lantus) and insulin lispro (authorized generic of Humalog) have been used by millions of patients. They typically cost 50 to 65% less than brand-name versions.
How do I get insulin for $35/month through the Lilly program?▼
Visit InsulinAffordability.com, register (no income verification needed), and receive a digital savings card. Present it at any participating pharmacy when filling a Lilly insulin prescription. The program covers Humalog, Humulin, Lyumjev, insulin lispro, and Rezvoglar. It works whether or not you have insurance. The cap is $35 per prescription per month.
Is Walmart ReliOn insulin the same as Humalog or NovoLog?▼
No. ReliOn insulin is human insulin (Regular and NPH), which is an older formulation. Humalog and NovoLog are analog insulins that work faster and have more predictable action profiles. ReliOn Regular takes 30 to 60 minutes to start working (versus 15 minutes for analogs), requiring more careful meal timing. It is safe and effective, but dosing is different. Never switch from analog to human insulin without consulting your doctor.
Does my state have an insulin price cap?▼
As of 2026, at least 25 states have enacted insulin copay caps ranging from $25 to $100 per month. California, Illinois, Maine, Washington, and New York all cap at $30 to $35. Colorado was the first at $100. These caps typically apply to state-regulated insurance plans only, not self-funded employer plans. Check your state insurance department website or call your insurer to confirm.
Can I buy insulin from Canada to save money?▼
Insulin that costs $300+ in the U.S. typically costs $30 to $50 in Canada for the same product. While the FDA generally prohibits drug importation, enforcement for personal-use quantities (90-day supply) is minimal. Some states have formal importation programs. Always purchase from CIPA-verified licensed Canadian pharmacies. Domestically, Mark Cuban Cost Plus Drugs offers some insulin products at near-international prices.
How do I ask my doctor to switch me to a cheaper insulin?▼
Be direct: “Cost is a concern. Can we switch to a biosimilar or authorized generic?” If you take Lantus, ask about Semglee or Rezvoglar. If you take Humalog, ask about insulin lispro. For interchangeable biosimilars, your pharmacist can often substitute automatically. Bring a printed list of alternatives and prices to your appointment so your doctor can see the savings.
Let CareRoute Fight Your Insulin Costs
Our Bill Defense team can identify the best savings programs for your specific insulin, appeal insurance denials, negotiate with providers, and make sure you are paying the absolute minimum. You only pay if we save you money.
Start Saving on Insulin